OR WAIT null SECS
May 02, 2007
USP exercises a vigorous standards-setting process that draws on both public comments and meticulous scientific review.
A recent benchmarking report on pharmaceutical manufacturing raises questions about the performance of contract manufacturers, but further analysis also raises concerns about the process and data used to arrive at this conclusion.
April 02, 2007
Inaccuracies in Chapter ‹1072› of the current USP 29 reveal problems in USP's revision and proofreading process.
Mishaps in packaging labels serve as a reminder: the recall is in the details.
To effectively grow in the biotech industry, companies must develop multiphase plans that focus on regulation and efficiency.
March 02, 2007
Just because the wheels are turning doesn't mean they're going forward.
The low-volume pharmaceutical industry must adapt Lean Manufacturing tools invented for high-volume, single product industries.
Before we can intelligently set the limits of process variation, we need to know what the clinical impact of that variation will be.
February 02, 2007
We, the people who make drugs, are extraordinarily good at what we do.
The role of micro-biological testing in real-time release is too important to ignore.